Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer

NCT01610869 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer

Interventions

DRUG: BIBF 1120

Sponsor

University College, London

Collaborators

[object Object]